Proapoptotic function of the nuclear Crk II adaptor protein

Biochemistry

Volumn 46, Issue 38, 2007, Pages 10828-10840

  Kar, Bishnupriya ^a   Reichman, Charles T ^a   Singh, Sukhwinder ^a   O'Connor, J Patrick ^a   Birge, Raymond B ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE; CYTOSKELETAL FUNCTIONS; NUCLEAR LOCALIZATION; PYCNOTIC NUCLEI;

CELL ADHESION; CELL DEATH; PHOSPHORYLATION; TISSUE CULTURE;

PROTEINS;

ABELSON KINASE; ADAPTOR PROTEIN; CELL CYCLE PROTEIN; CRK LIKE PROTEIN; GREEN FLUORESCENT PROTEIN; LEPTOMYCIN B; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEAR PROTEIN; PROTEIN CRK2; PROTEIN DOCK180; PROTEIN WEE1; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSKELETON; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CELL ADHESION; CELL COMPARTMENTATION; CELL CYCLE PROTEINS; CELL LINE; CYTOPLASM; CYTOSKELETAL PROTEINS; GREEN FLUORESCENT PROTEINS; HUMANS; KARYOPHERINS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN SORTING SIGNALS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-CRK; RAC GTP-BINDING PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; ULTRAVIOLET RAYS;

MAMMALIA;

EID: 34648834409     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi700537e     Document Type: Article

References (75)

1. Feller, S. M., et al. (1998) Physiological signals and oncogenesis mediated through Crk family adapter proteins, J. Cell. Physiol. 177, 535-552.
2. Mayer, B. J., Hamaguchi, M., and Hanafusa, H. (1988) A novel viral oncogene with structural similarity to phospholipase C, Nature 332, 272-275.
3. Tsuchie, H., et al. (1989) A newly isolated avian sarcoma virus, ASV-1, carries the crk oncogene, Oncogene 4, 1281-1284.
4. Matsuda, M., et al. (1992) Two species of human CRK cDNA encode proteins with distinct biological activities, Mol. Cell. Biol. 12, 3482-3489.
5. Reichman, C. T., et al. (1992) The product of the cellular crk gene consists primarily of SH2 and SH3 regions, Cell Growth Differ. 3, 451-460.
6. ten Hoeve, J., et al. (1993) Isolation and chromosomal localization of CRKL, a human crk-like gene, Oncogene 8, 2469-2474.
7. Imaizumi, T., et al. (1999) Mutant mice lacking Crk-II caused by the gene trap insertional mutagenesis: Crk-II is not essential for embryonic development, Biochem. Biophys. Res. Commun. 266, 569-574.
8. Guris, D. L., et al. (2001) Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome, Nat Genet. 27, 293-298.
9. Birge, R. B., et al. (1993) Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts, Mol. Cell. Biol. 13, 4648-4656.
10. Feller, S. M., Knudsen, B., and Hanafusa, H. (1995) Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways, Oncogene 10, 1465-1473.
11. Law, S. F., et al. (1996) Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae, Mol. Cell. Biol. 16, 3327-3337.
12. Vuori, K., et al. (1996) Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases, Mol. Cell. Biol. 16, 2606-2613.
13. Takai, S., et al. (1994) Mapping of the human C3G gene coding a guanine nucleotide releasing protein for Ras family to 9q34.3 by fluorescence in situ hybridization, Hum. Genet. 94, 549-550.
14. Tanaka, S., et al. (1994) C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins, Proc. Natl. Acad. Sci. U.S.A. 91, 3443-3447.
15. Knudsen, B. S., Feller, S. M., and Hanafusa, H. (1994) Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk, J. Biol. Chem. 269, 32781-32787.
16. Feller, S. M., Knudsen, B., and Hanafusa, H. (1994) c-Abl kinase regulates the protein binding activity of c-Crk, Embo J. 13, 2341-2351.
17. Garcia-Guzman, M., et al. (1999) Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1-Crk signaling complex formation, Oncogene 18, 7775-7786.
18. Girardin, S. E., and Yaniv, M. (2001) A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation, EMBO J. 20, 3437-3446.
19. Kodama, H., et al. (2003) Selective involvement of p130Cas/Crk/Pyk2/c-Src in endothelin-1-induced JNK activation, Hypertension 41, 1372-1379.
20. Mochizuki, N., et al. (2000) Crk activation of JNK via C3G and R-Ras, J. Biol. Chem. 275, 12667-12671.
21. Tanaka, S., Ouchi, T., and Hanafusa, H. (1997) Downstream of Crk adaptor signaling pathway: activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G, Proc. Natl. Acad. Sci. U.S.A. 94, 2356-2361.
22. Tanaka, S., and Hanafusa, H. (1998) Guanine-nucleotide exchange protein C3G activates JNK1 by a ras-independent mechanism. JNK1 activation inhibited by kinase negative forms of MLK3 and DLK mixed lineage kinases, J. Biol. Chem. 273, 1281-1284.
23. Leng, J., et al. (1999) Potentiation of cell migration by adhesion-dependent cooperative signals from the GTPase Rac and Raf kinase, J. Biol. Chem. 274, 37855-37861.
24. Reiske, H. R., et al. (1999) Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration, J. Biol. Chem. 274, 12361-12366.
25. Klemke, R. L., et al. (1998) CAS/Crk coupling serves as a "molecular switch" for induction of cell migration, J. Cell Biol. 140, 961-972.
26. Miller, C. T., et al. (2003) Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas, Oncogene 22, 7950-7957.
27. Linghu, H., et al. (2006) Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS, Oncogene 25, 3547-3556.
28. Watanabe, T., et al. (2006) Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines, Mol. Cancer Res. 4, 499-510.
29. Reichman, C., et al. (2005) Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain, Oncogene 24, 8187-8199.
30. Angers-Loustau, A., et al. (1999) Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts, J. Cell Biol. 144, 1019-1031.
31. Noren, N. K., et al. (2006) The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway, Nat. Cell Biol. 8, 815-825.
32. Rhodes, J., et al. (2000) CrkL functions as a nuclear adaptor and transcriptional activator in Bcr-Abl-expressing cells, Exp. Hematol. 28, 305-310.
33. Fish, E. N., et al. (1999) Activation of a CrkL-stat5 signaling complex by type I interferons, J. Biol. Chem. 274, 571-573.
34. Lekmine, F., et al. (2002) The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the small G-protein Rap1, Biochem. Biophys. Res. Commun. 291, 744-750.
35. Oda, A., et al. (2000) Thrombopoietin and interleukin-2 induce association of CRK with STAT5, Biochem. Biophys. Res. Commun. 278, 299-305.
36. Ota, J., et al. (1998) Association of CrkL with STAT5 in hematopoietic cells stimulated by granulocyte-macrophage colony-stimulating factor or erythropoietin, Biochem. Biophys. Res. Commun. 252, 779-786.
37. Ozaki, K., et al. (1998) Thrombopoietin induces association of Crkl with STAT5 but not STAT3 in human platelets, Blood 92, 4652-4662.
38. Evans, E. K., et al. (1997) Crk is required for apoptosis in Xenopus egg extracts, EMBO J. 16, 230-241.
39. Kornbluth, S. (1997) Apoptosis in Xenopus egg extracts, Methods Enzymol. 283, 600-614.
40. Smith, J. J., et al. (2000) Wee1-regulated apoptosis mediated by the crk adaptor protein in Xenopus egg extracts, J. Cell Biol. 151, 1391-1400.
41. Smith, J. J., et al. (2002) Apoptotic regulation by the Crk adapter protein mediated by interactions with Wee1 and Crm1/exportin, Mol. Cell. Biol. 22, 1412-1423.
42. Harkiolaki, M., et al. (2006) The C-terminal SH3 domain of CRKL as a dynamic dimerization module transiently exposing a nuclear export signal, Structure. 14, 1741-1753.
43. Willingham, M. C., Yamada, S. S., and Pastan, I. (1980) Ultrastructural localization of tubulin in cultured fibroblasts, J. Histochem. Cytochem. 28, 453-461.
44. Schreiber, V., et al. (1992) The human poly(ADP-ribose) polymerase nuclear localization signal is a bipartite element functionally separate from DNA binding and catalytic activity, EMBO J. 11, 3263-3269.
45. Feller, S. M. (2001) Crk family adaptors-signalling complex formation and biological roles, Oncogene 20, 6348-6371.
46. Schaller, M. D., and Schaefer, E. M. (2001) Multiple stimuli induce tyrosine phosphorylation of the Crk-binding sites of paxillin, Biochem. J. 360 (Part 1), 57-66.
47. Turner, C. E. (1998) Paxillin, Int. J. Biochem. Cell Biol. 30, 955-959.
48. Turner, C. E. (2000) Paxillin interactions, J. Cell Sci. 113 (Part 23), 4139-4140.
49. Valles, A. M., Beuvin, M., and Boyer, B. (2004) Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells, J. Biol. Chem. 279, 44490-44496.
50. Nautiyal, J., Kumar, P. G., and Laloraya, M. (2004) 17Beta-estradiol induces nuclear translocation of CrkL at the window of embryo implantation, Biochem. Biophys. Res. Commun. 318, 103-112.
51. Akakura, S., et al. (2001) A role for Hsc70 in regulating nucleocytoplasmic transport of a temperature-sensitive p53 (p53Val-135), J. Biol. Chem. 276, 14649-14657.
52. Kudo, N., et al. (1998) Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1, Exp. Cell Res. 242, 540-547.
53. Gali, P. (1979) Epithelial localization of pyruvate kinase L (ATP pyruvate phosphotransferase EC 2.7.1.40) in rat liver, C.R. Seances Acad. Sci. D 289, 1029-1032.
54. Gali, P., et al. (1980) Localization of pyruvate kinase M1 (ATP pyruvate phosphotransferase-2.7.1.40) in nervous tissue of the rat. Preliminary results, C.R. Seances Acad. Sci. D 290, 1533-1536.
55. Harper, J. V. (2005) Synchronization of cell populations in G1/S and G2/M phases of the cell cycle, Methods Mol. Biol. 296, 157-166.
56. Hayne, C., Tzivion, G., and Luo, Z. (2000) Raf-1/MEK/MAPK pathway is necessary for the G2/M transition induced by nocodazole, J. Biol. Chem. 275, 31876-31882.
57. Jordan, M. A., et al. (1996) Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death, Cancer Res. 56, 816-825.
58. Kim, Y. B., et al. (2000) Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells, J. Antibiot. (Tokyo) 53, 1191-1200.
59. Bernardi, R., et al. (1995) Activation of poly(ADP-ribose)-polymerase in apoptotic human cells, Biochimie 77, 378-384.
60. Barila, D., et al. (2003) Caspase-dependent cleavage of c-Abl contributes to apoptosis, Mol. Cell. Biol. 23, 2790-2799.
61. Kawai, H., Nie, L., and Yuan, Z. M. (2002) Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl, Mol. Cell. Biol. 22, 6079-6088.
62. Yoshida, K., and Miki, Y. (2005) Enabling death by the Abl tyrosine kinase: mechanisms for nuclear shuttling of c-Abl in response to DNA damage, Cell Cycle 4, 777-779.
63. Kain, K. H., Gooch, S., and Klemke, R. L. (2003) Cytoplasmic c-Abl provides a molecular 'Rheostat' controlling carcinoma cell survival and invasion, Oncogene 22, 6071-6080.
64. Wang, J. Y. (2000) Regulation of cell death by the Abl tyrosine kinase, Oncogene 19, 5643-5650.
65. Pendergast, A. M. (2005) Stress and death: breaking up the c-Abl/14-3-3 complex in apoptosis, Nat. Cell Biol. 7, 213-214.
66. Yoshida, K., et al. (2005) JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage, Nat. Cell Biol. 7, 278-285.
67. Holcomb, M., et al. (2006) Deregulation of proteasome function induces Abl-mediated cell death by uncoupling p130CAS and c-CrkII, J. Biol. Chem. 281, 2430-2440.
68. Aloisi, A., et al. (2006) BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B, Blood 107, 1591-1598.
69. Kiyokawa, E., et al. (1998) Activation of Rac1 by a Crk SH3-binding protein, DOCK180, Genes Dev. 12, 3331-3336.
70. Cote, J. F., and Vuori, K. (2002) Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity, J. Cell Sci. 115 (Part 24), 4901-4913.
71. Tosello-Trampont, A. C., et al. (2007) Identification of two signaling submodules within the CrkII/ELMO/Dock180 pathway regulating engulfment of apoptotic cells, Cell Death Differ. 14, 963-972.
72. Yin, J., et al. (2004) Nuclear localization of the DOCK180/ELMO complex, Arch. Biochem. Biophys. 429, 23-29.
73. Piwnica-Worms, H., et al. (1991) p107wee1 is a serine/threonine and tyrosine kinase that promotes the tyrosine phosphorylation of the cyclin/p34cdc2 complex, Cold Spring Harbor Symp. Quant. Biol. 56, 567-576.
74. Feilotter, H., et al. (1992) Regulation of the G2-mitosis transition, Biochem. Cell Biol. 70, 954-971.
75. Parker, L. L., and Piwnica-Worms, H. (1992) Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase, Science 257, 1955-1957.